Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kewaunee Scientific (KEQU) EBITDA Margin (2016 - 2026)

Kewaunee Scientific has reported EBITDA Margin over the past 17 years, most recently at 3.72% for Q1 2026.

  • Quarterly results put EBITDA Margin at 3.72% for Q1 2026, up 37.0% from a year ago — trailing twelve months through Jan 2026 was 6.95% (up 22.0% YoY), and the annual figure for FY2025 was 7.39%, down 159.0%.
  • EBITDA Margin for Q1 2026 was 3.72% at Kewaunee Scientific, down from 5.86% in the prior quarter.
  • Over the last five years, EBITDA Margin for KEQU hit a ceiling of 11.02% in Q2 2025 and a floor of 2.14% in Q1 2022.
  • Median EBITDA Margin over the past 5 years was 5.32% (2024), compared with a mean of 5.46%.
  • Biggest five-year swings in EBITDA Margin: surged 879bps in 2022 and later tumbled -479bps in 2025.
  • Kewaunee Scientific's EBITDA Margin stood at 1.38% in 2022, then skyrocketed by 632bps to 10.13% in 2023, then dropped by -8bps to 9.28% in 2024, then tumbled by -37bps to 5.86% in 2025, then plummeted by -37bps to 3.72% in 2026.
  • The last three reported values for EBITDA Margin were 3.72% (Q1 2026), 5.86% (Q4 2025), and 6.76% (Q3 2025) per Business Quant data.